Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) EBITDA Margin (2022 - 2023)

Historic EBITDA Margin for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to 29948.0%.

  • Lexeo Therapeutics' EBITDA Margin changed N/A to 29948.0% in Q4 2023 from the same period last year, while for Dec 2023 it was 33420.49%, marking a year-over-year change of. This contributed to the annual value of 71851.09% for FY2024, which is 394637800.0% up from last year.
  • According to the latest figures from Q4 2023, Lexeo Therapeutics' EBITDA Margin is 29948.0%.
  • In the past 5 years, Lexeo Therapeutics' EBITDA Margin ranged from a high of 38986.54% in Q3 2023 and a low of 3292.28% during Q3 2022